Latest news with #KratomConsumerProtectionActs
Associated Press
30-07-2025
- Health
- Associated Press
American Kratom Association Praises Secretary Kennedy and Commissioner Makary for Bold Action to Recommend Scheduling of Dangerous 7-OH Products
Commissioner Makary: 'We are not targeting the kratom leaf' American Kratom Association (AKA) today applauded Secretary Robert Kennedy and FDA Commissioner Dr. Marty Makary for their decisive and science-driven recommendation to classify 7-hydroxymitragynine (7-OH) as a Schedule I substance under the federal Controlled Substances Act. This bold step is a critical milestone in protecting public health and consumer safety from dangerous synthetic products that masquerade as natural kratom. 'Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public health threats related to mislabeled, manipulated psychoactive substances,' said Mac Haddow, senior fellow on public policy for the American Kratom Association. 'These 7-OH products are not kratom. They are chemically altered substances that carry potent opioid-like effects and pose an imminent threat to consumers. This move sends a clear and long-overdue message: the safety of the American public comes first.' 7-hydroxymitragynine is a metabolite — not a naturally occurring substance in the kratom plant — and occurs during the drying of kratom leaves at extremely low levels, typically less than 0.01%. However, unscrupulous manufacturers have exploited chemical manipulation to create concentrated 7-OH products that far exceed natural levels, creating high-potency, opioid-like effects that are addictive and potentially lethal. These products are often falsely marketed under the kratom name, misleading consumers and damaging the reputation of natural kratom, which has a vastly different safety profile. The American Kratom Association has worked tirelessly to educate policymakers, regulators, and the public on the difference between natural kratom products and chemically manipulated 7-OH formulations. The AKA has advocated for state-based Kratom Consumer Protection Acts (KCPA) to ban the sale of adulterated and dangerously enhanced products. This federal scheduling recommendation is a landmark development that supports those efforts and establishes a much-needed national framework to protect consumers. 'The FDA's own research shows that natural kratom has a relatively low potential for abuse and may offer harm-reduction benefits when used responsibly,' Haddow continued. 'It is the synthetic manipulation of 7-OH that has created the danger. The action by Secretary Kennedy and Commissioner Makary is not only scientifically justified, it is morally imperative.' The AKA urges swift action by the Drug Enforcement Administration (DEA) to initiate the rule-making process to schedule synthetically manipulated 7-hydroxymitragynine and to make clear that such action does not impact the legal status of natural kratom or its primary alkaloids, mitragynine and unaltered 7-OH occurring within the plant matrix. The goal is to eliminate the threat posed by rogue products while preserving access to safe, regulated kratom. 'We look forward to working with federal agencies and state policymakers to ensure that safe access to natural kratom is protected, while these dangerous imposters are removed from the marketplace,' said Haddow. Note: The FDA also released " Hiding in Plain Sight: 7-OH Products " to help educate the public. About American Kratom Association (AKA) American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit and learn more at Media Contact Mac Haddow [email protected] ### SOURCE: American Kratom Association (AKA) Copyright 2025 EZ Newswire
Reuters
29-07-2025
- Health
- Reuters
American Kratom Association Praises Secretary Kennedy and Commissioner Makary for Bold Action to Recommend Scheduling of Dangerous 7-OH Products
WASHINGTON, DC, July 29, 2025 (EZ Newswire) -- American Kratom Association (AKA), opens new tab today applauded Secretary Robert Kennedy and FDA Commissioner Dr. Marty Makary for their decisive and science-driven recommendation to classify 7-hydroxymitragynine (7-OH) as a Schedule I substance under the federal Controlled Substances Act. This bold step is a critical milestone in protecting public health and consumer safety from dangerous synthetic products that masquerade as natural kratom. 'Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public health threats related to mislabeled, manipulated psychoactive substances,' said Mac Haddow, senior fellow on public policy for the American Kratom Association. 'These 7-OH products are not kratom. They are chemically altered substances that carry potent opioid-like effects and pose an imminent threat to consumers. This move sends a clear and long-overdue message: the safety of the American public comes first.' 7-hydroxymitragynine is a metabolite — not a naturally occurring substance in the kratom plant — and occurs during the drying of kratom leaves at extremely low levels, typically less than 0.01%. However, unscrupulous manufacturers have exploited chemical manipulation to create concentrated 7-OH products that far exceed natural levels, creating high-potency, opioid-like effects that are addictive and potentially lethal. These products are often falsely marketed under the kratom name, misleading consumers and damaging the reputation of natural kratom, which has a vastly different safety profile. The American Kratom Association has worked tirelessly to educate policymakers, regulators, and the public on the difference between natural kratom products and chemically manipulated 7-OH formulations. The AKA has advocated for state-based Kratom Consumer Protection Acts (KCPA) to ban the sale of adulterated and dangerously enhanced products. This federal scheduling recommendation is a landmark development that supports those efforts and establishes a much-needed national framework to protect consumers. 'The FDA's own research shows that natural kratom has a relatively low potential for abuse and may offer harm-reduction benefits when used responsibly,' Haddow continued. 'It is the synthetic manipulation of 7-OH that has created the danger. The action by Secretary Kennedy and Commissioner Makary is not only scientifically justified, it is morally imperative.' The AKA urges swift action by the Drug Enforcement Administration (DEA) to initiate the rule-making process to schedule synthetically manipulated 7-hydroxymitragynine and to make clear that such action does not impact the legal status of natural kratom or its primary alkaloids, mitragynine and unaltered 7-OH occurring within the plant matrix. The goal is to eliminate the threat posed by rogue products while preserving access to safe, regulated kratom. 'We look forward to working with federal agencies and state policymakers to ensure that safe access to natural kratom is protected, while these dangerous imposters are removed from the marketplace,' said Haddow. Note: The FDA also released "Hiding in Plain Sight: 7-OH Products, opens new tab" to help educate the public. About American Kratom Association (AKA) American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit and learn more at Media Contact Mac Haddowpress@ ### SOURCE: American Kratom Association (AKA) Copyright 2025 EZ Newswire See release on EZ Newswire
Associated Press
18-07-2025
- Health
- Associated Press
National Consumer Alert on 7-OH Products Posing Significant Dangers
FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain 7-hydroxymitragynine (7-OH) and advises consumers that these products pose significant dangers American Kratom Association (AKA) is issuing a national consumer alert to warn consumers, retailers, and distributors of the serious health risks posed by products that contain dangerously high levels of 7-hydroxymitragynine (7-OH) — a powerful, highly psychoactive compound that is not naturally present in kratom leaf in any meaningful amount. The warning letters appropriately include 7-OH + pseudoindoxyl products that are an enhanced manipulation of the naturally occurring kratom compounds. The U.S. Food and Drug Administration (FDA) has recently issued multiple warning letters to companies selling these adulterated and illegal products, making it unequivocally clear: 7-OH products are unsafe, misleadingly marketed, and violate federal law. Why Consumers Should Be Concerned Retailers and Manufacturers Beware The AKA applauds the FDA's long-overdue action to protect consumers and remove these hazardous products from the marketplace. For years, AKA has advocated for commonsense regulations through state-level Kratom Consumer Protection Acts (KCPAs) that clearly prohibit dangerous alkaloid manipulation, including limits on 7-OH to no more than 2% of total alkaloid content—a threshold that corresponds with less than 1 mg per serving. What Consumers Can Do Additional Resources The Bottom Line: If it's not natural kratom, it's not kratom. About American Kratom Association (AKA) American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit and learn more at Media Contact Mac Haddow [email protected] ### SOURCE: American Kratom Association (AKA) Copyright 2025 EZ Newswire
Reuters
18-07-2025
- Health
- Reuters
National Consumer Alert on 7-OH Products Posing Significant Dangers
WASHINGTON, DC, July 18, 2025 (EZ Newswire) -- American Kratom Association (AKA), opens new tab is issuing a national consumer alert to warn consumers, retailers, and distributors of the serious health risks posed by products that contain dangerously high levels of 7-hydroxymitragynine (7-OH) — a powerful, highly psychoactive compound that is not naturally present in kratom leaf in any meaningful amount. The warning letters appropriately include 7-OH + pseudoindoxyl products that are an enhanced manipulation of the naturally occurring kratom compounds. The U.S. Food and Drug Administration (FDA) has recently issued multiple warning letters to companies selling these adulterated and illegal products, making it unequivocally clear: 7-OH products are unsafe, misleadingly marketed, and violate federal law. Why Consumers Should Be Concerned Retailers and Manufacturers Beware The AKA applauds the FDA's long-overdue action to protect consumers and remove these hazardous products from the marketplace. For years, AKA has advocated for commonsense regulations through state-level Kratom Consumer Protection Acts (KCPAs) that clearly prohibit dangerous alkaloid manipulation, including limits on 7-OH to no more than 2% of total alkaloid content—a threshold that corresponds with less than 1 mg per serving. What Consumers Can Do Additional Resources The Bottom Line: If it's not natural kratom, it's not kratom. About American Kratom Association (AKA) American Kratom Association (AKA) is a consumer-based, nonprofit organization, focused on furthering the latest science as guidance for kratom public policy. AKA works to give a voice to millions of Americans by fighting to protect their rights to access safe and natural kratom. For more information, visit and learn more at Media Contact Mac Haddowpress@ ### SOURCE: American Kratom Association (AKA) Copyright 2025 EZ Newswire See release on EZ Newswire
